Clinical relevance of immunoactive mistletoe lectin-I

Anti-Cancer Drugs

Volumn 8, Issue SUPPL. 1, 1997, Pages

  Beuth, J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

BALB c mice; Cancer patients; Immunomodulation; Immunoprotection; Mistletoe lectin I; Mistletoe lectin II; Quality of life

Indexed keywords

CARBOHYDRATE; GALACTOSIDE; PLANT EXTRACT; UNCLASSIFIED DRUG; VISCUM ALBUM LECTIN; VISCUM ALBUM LECTIN I; VISCUM ALBUM LECTIN II;

ANIMAL MODEL; CANCER; CANCER RECURRENCE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; GLIOMA; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; METASTASIS; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; VISCUM ALBUM;

EID: 0030999014     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199704001-00012     Document Type: Conference Paper

References (19)

1. Hanna N: Natural killer-cell mediated inhibition of tumor metastasis in vivo. Surv Synth Path 1983; 2: 68-81.
2. Beuth J, Ko HL, Tunggal L, Pulverer G: Mistletoe lectin as an immunomodulator in adjuvant therapy [in German], Dtsch Ztsch Onkol 1993; 25: 73-76.
3. Braun M, Gemmell CG, Beuth J, Ko HL, Pulverer G: Respiratory burst of human polymorphonuclear leukocytes in response to the galactoside-specific mistletoe lectin. Zentralblatt Bakteriologie 1995; 283: 90-94.
4. Beuth J, Ko HL, Tunggal L, Jeljaszewicz J, Steuer MK, Pulverer G: Effect of mistletoe lectin in standardized extracts on the in vitro proliferation of malignant and non-malignant cells [in German]. Disch Ztsch Onkol 1994 26: 1-6.
5. Beuth J, Ko HL, Gabius H-J, Pulverer G: Influence of treatment with the immunomodulatory effective dose of β-galactoside-specific lectin from mistletoe on tumor colonization in BALB/ c-mice for two experimental model systems. In vivo 1991; 5: 29-32.
6. Beuth J, Ko HL, Tunggal L, et al: Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-I . In vivo 1993; 7: 407-410.
7. Beuth J, Ko HL, Tunggal L, et al.: Immunoactive capacity of mistletoe lectin-I , dependent on dose [in German]. Arzneim-Forsch/Drug Res 1994; 44: 1255-1258.
8. Beuth J, Ko HL, Tunggal L. et al.: Immunoprotective activity of the galactoside specific mistletoe lectin in cortisone treated BALB/c-mice. In vivo 1994; 8: 898-992.
9. Stoffel B, Beuth J, Pulverer G: Effect of immunomodulation with galactoside-specific mistletoe lectin on experimental listeriosis. Zentralblatt Bakteriologie 1996; 284: 439-442.
10. Beuth J, Stoffel B, Ko HL, Jeljaszewicz J, Pulverer G: Immunomodulating ability of galactoside-specific lectin standardized and depleted mistletoe extract. Arzneim-Forsch/Drug Res 1995, 45: 1240-1242.
11. Beuth J, Stoffel B, Samtlehen R, et al.: Modulating activity of mistletoe lectins 1 and 2 on the lymphatic system in BALB/c-mice. Phytomedicine 1996; 2: 269-273.
12. Beuth J, Ko HL, Gabius H-J, Burrichter H, Oette K, Pulverer G: Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients. Clin Invest 1992; 70: 658-661.
13. Beuth J, Ko HL, Tunggal L, Geisel J, Pulverer G: Comparison of the immunoactive capacity of purified mistletoe lectin-I and the mistletoe lectin standardized extract [in German]. Arzneim-Forsch/Drug Res 1993; 43: 166-169.
14. Beuth J, Gabius H-J, Steuer MK, et al.: Influence of mistletoe lectin-I on the level of acute phase reactants in tumour patients [in German]. Medizinische Klinik 1993; 88: 287-290.
15. Heiny BM, Beuth J: Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces β-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res 1994; 14: 1339-1342.
16. Beuth J, Stoffel B, Ko HL, Buss G, Tunggal L, Pulverer G: Immunoactive capacity of different mistletoe lectin-I closes in breast cancer patients [in German]. Arzneim-Forsch/Drug Res 1995, 45: 505-507.
17. Krieger D: Brain peptides: what? where? why? Science 1983, 226: 975-980.
18. Heijnen CJ, Kavelaars A, Ballieux RE: Beta-endorphin: cytokine and neuropeptide. Immunol Res 1991; 119: 41-63.
19. Lenartz D, Stoffel B, Menzel J, Beuth J: Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive therapy in glioma patients. Anticancer Res 1996, 16: 3799-3802.